γ-谷氨酰转肽酶对恶性肿瘤预后的评价  

Gama-glutamyltransferase and prognosis evaluation of malignant tumor

作　　者：赵玥 王天娇[1] 吴瑾[1] Zhao Yue;Wang Tianjiao;Wu Jin(Department of Oncology,Harbin Medical University Cancer Hospital,Heilongjiang Harbin 150081,China.)

机构地区：[1]哈尔滨医科大学附属肿瘤医院内七科,黑龙江哈尔滨150081

出　　处：《现代肿瘤医学》2018年第18期2976-2979,共4页Journal of Modern Oncology

基　　金：海燕基金重点项目(编号:JJZD2014-05)

摘　　要：研究报道生化指标可以作为独立预测多种恶性肿瘤预后的生物标志物。近年来越来越多的研究提示γ-谷氨酰转肽酶(gama-glutamyltransferase,γ-GGT)可能成为多种恶性肿瘤的新的预测指标,本文就γ-GGT对多种恶性肿瘤预后评价作一综述。Biochemical markers can be used as a biomarker for independent predictors of the prognosis of various malignancies.In recent years,more and more studies have suggested that gama-glutamyltransferase（ γ-GGT） may be a novel predictor of various malignant tumors,this article reviews the value of γ-GGT in the evaluation of the prognosis of the patients with malignant tumor.

关 键 词：γ-GGT 肿瘤 预后 

分 类 号：R730.7[医药卫生—肿瘤]